ELIZABETH SCHMIDT: Open Payments
NPI 1972048700 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$976 in 61 payments from 10 companies in 2025. Trend: 2023 $1,623 · 2024 $1,347 · 2025 $976
Food & beverage: $976
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $300 |
| GENZYME CORPORATION | 10 | $205 |
| Janssen Biotech, Inc. | 10 | $140 |
| Lilly USA, LLC | 9 | $109 |
| UCB, Inc. | 4 | $82 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| Incyte Corporation | 1 | $22 |
| Galderma Laboratories, L.P. | 1 | $18 |
| PFIZER INC. | 1 | $16 |
Products named: DUPIXENT, RINVOQ, TREMFYA, SKYRIZI, TALTZ, Bimzelx, Rhapsido, OPZELURA.
Industry payments across OR — which companies pay providers there.
